Within a few decades, transplant patients might opt for ‘lab-grown’ organs, rather than waiting years in donor-organ queues. The technology fueling this shift is 3D bioprinting. Working in the same way as 3D printers, bioprinters deposit layers of biomaterial, that may include living cells, to build complex structures like skin tissue or blood vessels. Bioprinting is providing doctors with new options for treatment and has the potential to be the next big thing in healthcare and personalised medicine.
Sep 01 2021